Golden Meds Dispensaries Upgrade to BLAZE Software for Retail Management

1.5 min readPublished On: December 24th, 2021By

LOS ANGELES – BLAZE®, enterprise resource planning and point-of-sale (POS) platform for legal cannabis, is excited to announce that Golden Meds will be the largest Colorado-based multi-location dispensary to adopt and implement their retail platform. The switch to BLAZE comes just in time for the new year as Golden Meds will be rolling out the new POS system in all nine existing stores throughout the Denver Metro area.

“We’re looking forward to this partnership with BLAZE. We wanted a software provider that could handle multiple locations and bring synergy under one platform. As we scale our business, we feel confident that BLAZE can scale with us to reach our goals.” Washington Charles, Golden Meds VP of Operations

The upgrade to BLAZE Retail and BLAZEPay will streamline the day to day operations for POS transactions and card payments. Golden Meds will be able to manage their business with a bevy of new features, simplified workflows, and improved integration opportunities. As a new software player in the Colorado cannabis industry, BLAZE is making waves by offering retail software that can accomodate in-store sales, online sales, pick-up, and delivery. The BLAZE ERP platform is sophisticated enough to help enforce the new stricter medical marijuana purchase limits in Colorado that will take effect in January of 2022.

“We’re very excited to add Golden Meds to the BLAZE family. This is a great partnership and win for us in the Colorado market. As a Native to Colorado I am extremely excited and ready to have more of my Coloradans experience our awesome Seed to Sale software. We are the game changer in the CO market and Industry.” Eric Bellas, BLAZE Head of Sales.

(This information is primarily sourced from BLAZE.  Highly Capitalized has neither approved nor disapproved the contents of this news release. Read our Disclaimer here).

About the Author: News Team

Newsteam at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Share This Story, Choose Your Platform!

Latest News